[Induced systemic lupus erythematosus].
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000927:Anticonvulsants / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000009:adverse effects; D013956:Antithyroid Agents / Q000009:adverse effects; D000995:Antitubercular Agents / Q000009:adverse effects; D003276:Contraceptives, Oral / Q000009:adverse effects; D005260:Female; D006168:Guinea Pigs; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced*; D008297:Male; D013449:Sulfonamides / Q000009:adverse effects
D000889:Anti-Arrhythmia Agents; D000900:Anti-Bacterial Agents; D000927:Anticonvulsants; D000959:Antihypertensive Agents; D013956:Antithyroid Agents; D000995:Antitubercular Agents; D003276:Contraceptives, Oral; D013449:Sulfonamides
Liszaj rumieniowaty uogólniony--indukowany